TGFBR1 (Transforming Growth Factor Beta Receptor 1) is a critical component of TGF-beta signaling in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
Overview
TGFBR1 (Transforming Growth Factor Beta Receptor 1) encodes the transmembrane serine/threonine kinase receptor that mediates TGF-beta signaling in the central nervous system[@massague2012][@todo2020]. As the primary type I receptor for TGF-beta ligands, TGFBR1 plays essential roles in regulating neuroinflammation, neuronal survival, synaptic plasticity, and glial cell function[@luo2019].
TGFBR1 (Transforming Growth Factor Beta Receptor 1) is a critical component of TGF-beta signaling in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
Overview
TGFBR1 (Transforming Growth Factor Beta Receptor 1) encodes the transmembrane serine/threonine kinase receptor that mediates TGF-beta signaling in the central nervous system[@massague2012][@todo2020]. As the primary type I receptor for TGF-beta ligands, TGFBR1 plays essential roles in regulating neuroinflammation, neuronal survival, synaptic plasticity, and glial cell function[@luo2019].
Gene Information
Protein Structure and Function
TGFBR1 is a transmembrane receptor kinase consisting of:
Extracellular domain: Contains cysteine-rich regions that mediate ligand binding
Cytoplasmic serine/threonine kinase domain: Mediates downstream signaling through phosphorylation
Upon ligand binding to the type II receptor (TGFBR2), TGFBR1 is recruited and transphosphorylated at key serine/threonine residues, activating its kinase domain[@heldin2021].
Functions in the Nervous System
TGF-beta signal initiation: Primary mediator of TGF-beta1, TGF-beta2, and TGF-beta3 signaling[@gordon2020]
Neuroinflammation regulation: Controls microglial activation and pro-inflammatory cytokine production[@brionne2021]
Neuronal survival: Mediates TGF-beta-induced neuroprotective effects through SMAD2/SMAD3 signaling[@kane2018]
Synaptic plasticity: Modulates excitatory synaptic transmission and [long-term potentiation](/mechanisms/long-term-potentiation)[@ferguson2019]
[Blood-brain barrier](/entities/blood-brain-barrier) integrity: Regulates endothelial cell function and BBB maintenance[@tichauer2020]
Expression in the Brain
TGFBR1 is expressed throughout the brain:
[Neurons](/entities/neurons): Moderate expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum[@stipursky2018]
[Astrocytes](/entities/astrocytes): High expression, particularly in reactive astrocytes[@hamby2020]
[Microglia](/cell-types/microglia-neuroinflammation): Present in resting and activated microglial states[@liu2021]
Endothelial cells: Expressed in cerebral blood vessels[@nitta2019]
Oligodendrocytes: Expression in mature oligodendrocytes[@palazuelos2021]
Role in Neurodegeneration
Alzheimer's Disease
TGFBR1 signaling is altered in AD brain, with changes in both neurons and glia[@caraci2021]
TGF-beta signaling deficits may contribute to increased neuroinflammation in AD[@tolar2020]
Impaired TGF-beta signaling may affect amyloid clearance mechanisms[@wysscoray2020]
Reduced TGFBR1 expression correlates with cognitive decline in AD patients[@mousseau2021]
Parkinson's Disease
TGFBR1 plays a role in protecting dopaminergic neurons from oxidative stress[@rai2022]
TGF-beta signaling may modulate [alpha-synuclein](/proteins/alpha-synuclein) toxicity[@reynolds2021]
Altered TGFBR1 expression observed in PD substantia nigra[@tong2019]
Amyotrophic Lateral Sclerosis
TGF-beta signaling through TGFBR1 may influence motor neuron survival[@dormann2020]
Dysregulation of TGF-beta pathway components in ALS motor cortex[@ilieva2019]
Frontotemporal Dementia
TGFBR1 signaling linked to progranulin-mediated neuronal survival[@minami2020]
Therapeutic Implications
Small molecule inhibitors: TGFBR1 kinase inhibitors being explored for various conditions[@akhurst2021]
TGF-beta agonists: Activation of TGFBR1 signaling may have neuroprotective effects[@sakauchi2021]
Gene therapy approaches: Targeting TGFBR1 expression for neurodegenerative diseases[@endo2022]
Key Publications
[Massague et al., TGF-beta signaling in development and disease (2012)](https://doi.org/10.1016/j.tcb.2012.06.002)
[Todo et al., TGF-beta signaling in the nervous system (2020)](https://doi.org/10.1016/j.pneurobio.2020.101843)
[Caraci et al., TGF-beta alterations in Alzheimer's disease (2021)](https://doi.org/10.3233/JAD-210120)
[Rai et al., TGF-beta protection in dopaminergic neurons (2022)](https://doi.org/10.1016/j.redox.2022.102281)
See Also
[TGF-beta Signaling Pathway in Neurodegeneration](/mechanisms/tgf-beta-signaling-pathway)
The study of Tgfbr1 — Transforming Growth Factor Beta Receptor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Massague J, et al, TGF-beta signaling in development and disease (2012)](https://doi.org/10.1016/j.tcb.2012.06.002)
[Todo R, et al, TGF-beta in the nervous system: roles in neurodegeneration and repair (2020)](https://doi.org/10.1016/j.pneurobio.2020.101843)
Luo J, et al, TGF-beta in CNS neurodegeneration (2019)
Heldin CH, et al, TGF-beta signaling from a developmental perspective (2021)
Gordon KJ, Blobe GC, Role of TGF-beta in neuroprotection and neurodegeneration (2020)
Brionne TC, et al, Loss of TGF-beta signaling in neurons leads to neuroinflammation (2021)
Kane CJ, et al, TGF-beta neuroprotection in models of Parkinson's disease (2018)
Ferguson L, et al, TGF-beta and synaptic plasticity in the hippocampus (2019)
Tichauer JE, et al, TGF-beta and blood-brain barrier in neurodegeneration (2020)
Stipursky J, et al, TGF-beta/Smad signaling in neurons (2018)
Hamby ME, et al, TGF-beta in astrocyte function (2020)
Liu J, et al, TGF-beta signaling in microglia (2021)
Nitta A, et al, TGF-beta and endothelial function in the BBB (2019)
Palazuelos J, et al, TGF-beta in oligodendrocyte biology (2021)
Caraci F, et al, TGF-beta alterations in Alzheimer's disease (2021)
Tolar M, et al, TGF-beta and neuroinflammation in AD (2020)
Wyss-Coray T, et al, TGF-beta and amyloid clearance (2020)
Mousseau M, et al, TGFBR1 expression and cognitive decline (2021)
Rai SN, et al, TGF-beta protection in dopaminergic neurons (2022)
Reynolds CH, et al, TGF-beta and alpha-synuclein interaction (2021)
Tong J, et al, TGFBR1 in Parkinson's disease substantia nigra (2019)
Dormann D, et al, TGF-beta in ALS motor neuron disease (2020)
Ilieva H, et al, TGF-beta pathway in ALS (2019)
Minami SS, et al, Progranulin and TGF-beta signaling (2020)
Akhurst RJ, et al, TGFBR1 kinase inhibitors in disease therapy (2021)
Sakauchi M, et al, TGF-beta agonists for neuroprotection (2021)
Endo F, et al, Gene therapy targeting TGFBR1 (2022)